Drug Control:

The Office of National Drug Control Policy Should Develop Key Planning Elements to Meet Statutory Requirements

GAO-20-124: Published: Dec 18, 2019. Publicly Released: Dec 18, 2019.

Additional Materials:

Contact:

Triana McNeil
(202) 512-8777
McNeilT@gao.gov

 

Mary Denigan-Macauley, Ph.D.
(202) 512-7114
deniganmacauleym@gao.gov

 

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

The Office of National Drug Control Policy (ONDCP) oversees and coordinates federal drug policy. In 2018, new legislation reauthorized ONDCP and imposed a number of new requirements.

We found that ONDCP met some of the new requirements. For instance, ONDCP designated officials for two new coordinator positions. However, ONDCP does not have key planning elements needed to ensure it can meet other requirements related to, for example, its online database of drug control data.

We recommended that ONDCP develop these planning elements to meet these requirements.

A drug law book on a desk next to a notepad, pen, and folder

A drug law book on a desk next to a notepad, pen, and folder

Additional Materials:

Contact:

Triana McNeil
(202) 512-8777
McNeilT@gao.gov

 

Mary Denigan-Macauley, Ph.D.
(202) 512-7114
deniganmacauleym@gao.gov

 

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

What GAO Found

The Office of National Drug Control Policy (ONDCP) is responsible for overseeing and coordinating the development and implementation of U.S. drug control policy across the federal government. However, ONDCP did not issue a National Drug Control Strategy for either 2017 or 2018, as required by statute. ONDCP was also required to assess and certify federal agencies' drug control budgets to determine if they were adequate to meet Strategy goals and objectives. Without a Strategy in 2017 and 2018, ONDCP could not complete this process according to statutory requirements. ONDCP issued a 2019 Strategy and companion documents that addressed some but not all of the selected statutory requirements GAO reviewed. For example, the Strategy and companion documents did not include the required 5-year projection for budget priorities.

HL_5 - 103016

The October 2018 Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) retained some requirements and introduced new ones for ONDCP. ONDCP met some SUPPORT Act requirements GAO reviewed. For example, ONDCP filled all five coordinator positions described in the SUPPORT Act. However, its approach to meeting other requirements does not incorporate key planning elements. For example, the SUPPORT Act requires that future iterations of the Strategy include a description of how each goal will be achieved, performance evaluation plans, and a plan for expanding treatment of substance use disorders. ONDCP could not provide in writing or otherwise describe its planned steps, interim milestones, resource investments, or overall timeframes—all key planning elements—that would provide assurance it can meet these requirements by the deadline for the next Strategy—February 2020. The SUPPORT Act also required ONDCP to publish an online searchable Data Dashboard of drug control data, with information including quantities of drugs and frequency of their use. While ONDCP published (and later updated) a public version of this resource on its website, as of December 2019, it was not complete (e.g., lacked required data on the unmet need for substance use disorder treatment). Further, ONDCP officials had no information on next steps for fully meeting the requirements. Developing, documenting, and implementing key planning elements to meet these requirements—including resource investments, time frames, and any processes, policies, roles, and responsibilities—would be consistent with key principles for achieving an entity's objective and standards for project management. Importantly, doing so would help ONDCP structure its planning efforts and comply with the law.

Why GAO Did This Study

Almost 70,000 people died from drug overdoses in 2018, according to the latest Centers for Disease Control and Prevention data. The 2018 SUPPORT Act reauthorized ONDCP and imposed new requirements. GAO noted in its March 2019 High Risk report that the federal effort to prevent drug misuse is an emerging issue requiring close attention.

Pursuant to 21 U.S.C. § 1708a(b), GAO has periodically assessed ONDCP's programs and operations. This report assesses the extent to which ONDCP (1) met selected statutory requirements related to the National Drug Control Strategy in 2017, 2018, and 2019, and (2) has planned or implemented actions to meet selected new requirements in the SUPPORT Act. GAO assessed the 2019 Strategy and companion documents against four key statutory requirements that were consistent with or similar to ONDCP's ongoing responsibilities under the SUPPORT Act. GAO also assessed ONDCP's progress in addressing seven new SUPPORT Act requirements, and interviewed ONDCP officials.

What GAO Recommends

GAO is making 4 recommendations to ONDCP to develop, document, and implement key planning elements to meet certain requirements in the SUPPORT Act. ONDCP agreed to implement 2 recommendations related to the Strategy, but disagreed with 2 related to the Drug Control Data Dashboard, noting that recent updates satisfy the law. GAO maintains that they do not fully do so, and that implementing key planning elements would help address the law, as discussed in the report.

For more information, contact Triana McNeil at (202) 512-8777 or McNeilT@gao.gov; Mary Denigan-Macauley at (202) 512-7114 or DeniganMacauleyM@gao.gov.

Recommendations for Executive Action

  1. Status: Open

    Comments: ONDCP provided some information on August 17, 2020 regarding the steps it has taken, and we are awaiting additional documentation for this recommendation. For example, ONDCP officials stated they have begun developing procedures for internal use to guide the development of future National Drug Control Strategies.

    Recommendation: The Director of ONDCP should develop and document key planning elements to help the agency meet the SUPPORT Act requirements for the 2020 National Drug Control Strategy and future Strategy iterations. These planning elements should include descriptions of resource investments, time frames, and any processes, policies, roles, and responsibilities needed to address each requirement. (Recommendation 1)

    Agency Affected: Executive Office of the President: Office of National Drug Control Policy

  2. Status: Open

    Comments: ONDCP provided some information on August 17, 2020 regarding the steps it has taken, and we are awaiting additional documentation for this recommendation. For example, ONDCP officials stated they have begun developing procedures for internal use to guide the development of future National Drug Control Strategies.

    Recommendation: The Director of ONDCP should—after developing and documenting key planning elements to meet the SUPPORT Act requirements—routinely implement an approach, based on these planning elements, to meet the requirements for the 2020 National Drug Control Strategy and future Strategy iterations. (Recommendation 2)

    Agency Affected: Executive Office of the President: Office of National Drug Control Policy

  3. Status: Open

    Comments: ONDCP provided some information on August 17, 2020 regarding the steps it has taken, and we are awaiting additional documentation for this recommendation. For example, according to ONDCP officials, ONDCP updated the Drug Control Data Dashboard in February 2020 to include enhanced functionality and improved searches.

    Recommendation: The Director of ONDCP should develop and document key planning elements to help the agency meet the SUPPORT Act requirements to establish a Drug Control Data Dashboard that would include descriptions of resource investments, time frames, and any processes, policies, or roles, and responsibilities needed to address this requirement. (Recommendation 3)

    Agency Affected: Executive Office of the President: Office of National Drug Control Policy

  4. Status: Open

    Comments: ONDCP provided some information on August 17, 2020 regarding the steps it has taken, and we are awaiting additional documentation for this recommendation. For example, according to ONDCP officials, ONDCP updated the Drug Control Data Dashboard in February 2020 to include enhanced functionality and improved searches.

    Recommendation: The Director of ONDCP should—after developing and documenting key planning elements—implement an approach, based on these planning elements, to meet the SUPPORT Act requirements to establish a Drug Control Data Dashboard. (Recommendation 4)

    Agency Affected: Executive Office of the President: Office of National Drug Control Policy

 

Explore the full database of GAO's Open Recommendations »

Oct 26, 2020

Sep 30, 2020

Sep 10, 2020

Sep 8, 2020

Aug 13, 2020

Jul 29, 2020

Jul 8, 2020

Jun 22, 2020

May 26, 2020

May 12, 2020

Looking for more? Browse all our products here